Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C27H49N5O8 |
| Molecular Weight | 571.7067 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCCCCCCC(=O)N[C@@H](C)C(=O)N[C@H](CCC(=O)N[C@@H](CCC[C@H](N)C(N)=O)C(O)=O)C(O)=O
InChI
InChIKey=TUNXCNXMSJZNPO-XSDIEEQYSA-N
InChI=1S/C27H49N5O8/c1-3-4-5-6-7-8-9-10-11-15-22(33)30-18(2)25(36)32-21(27(39)40)16-17-23(34)31-20(26(37)38)14-12-13-19(28)24(29)35/h18-21H,3-17,28H2,1-2H3,(H2,29,35)(H,30,33)(H,31,34)(H,32,36)(H,37,38)(H,39,40)/t18-,19-,20-,21+/m0/s1
| Molecular Formula | C27H49N5O8 |
| Molecular Weight | 571.7067 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Tabilautide (also known as RP 56142) is a tripeptide derivative patented by Rhone-Poulenc Industries S. A. as an immune adjuvant. In preclinical studies, Tabilautide displays potent protective activities against bacterial infections such as K. pneumoniae, L. monocytogenes or S. Typhimurium. Besides that Tabilautide shows antimetastatic activity and induces macrophage activation and enhanced cytotoxicity of natural killer cells in spleen, blood, and liver. These activities correlate with prophylactic and therapeutic effects of Tabilautide on artificial liver metastases of histiocytosarcoma.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:32:03 GMT 2025
by
admin
on
Mon Mar 31 18:32:03 GMT 2025
|
| Record UNII |
EZ61NB05TG
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C308
Created by
admin on Mon Mar 31 18:32:03 GMT 2025 , Edited by admin on Mon Mar 31 18:32:03 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
Tabilautide
Created by
admin on Mon Mar 31 18:32:03 GMT 2025 , Edited by admin on Mon Mar 31 18:32:03 GMT 2025
|
PRIMARY | |||
|
6241
Created by
admin on Mon Mar 31 18:32:03 GMT 2025 , Edited by admin on Mon Mar 31 18:32:03 GMT 2025
|
PRIMARY | |||
|
EZ61NB05TG
Created by
admin on Mon Mar 31 18:32:03 GMT 2025 , Edited by admin on Mon Mar 31 18:32:03 GMT 2025
|
PRIMARY | |||
|
SUB10793MIG
Created by
admin on Mon Mar 31 18:32:03 GMT 2025 , Edited by admin on Mon Mar 31 18:32:03 GMT 2025
|
PRIMARY | |||
|
CHEMBL2375145
Created by
admin on Mon Mar 31 18:32:03 GMT 2025 , Edited by admin on Mon Mar 31 18:32:03 GMT 2025
|
PRIMARY | |||
|
DTXSID00228722
Created by
admin on Mon Mar 31 18:32:03 GMT 2025 , Edited by admin on Mon Mar 31 18:32:03 GMT 2025
|
PRIMARY | |||
|
3086083
Created by
admin on Mon Mar 31 18:32:03 GMT 2025 , Edited by admin on Mon Mar 31 18:32:03 GMT 2025
|
PRIMARY | |||
|
C76570
Created by
admin on Mon Mar 31 18:32:03 GMT 2025 , Edited by admin on Mon Mar 31 18:32:03 GMT 2025
|
PRIMARY | |||
|
78088-46-7
Created by
admin on Mon Mar 31 18:32:03 GMT 2025 , Edited by admin on Mon Mar 31 18:32:03 GMT 2025
|
PRIMARY | |||
|
100000082992
Created by
admin on Mon Mar 31 18:32:03 GMT 2025 , Edited by admin on Mon Mar 31 18:32:03 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |